MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4.
Sonkoly E, Janson P, Majuri ML, Savinko T, Fyhrquist N, Eidsmo L, Xu N, Meisgen F, Wei T, Bradley M, Stenvang J, Kauppinen S, Alenius H, Lauerma A, Homey B, Winqvist O, Ståhle M, Pivarcsi A.
Sonkoly E, et al. Among authors: winqvist o.
J Allergy Clin Immunol. 2010 Sep;126(3):581-9.e1-20. doi: 10.1016/j.jaci.2010.05.045. Epub 2010 Jul 31.
J Allergy Clin Immunol. 2010.
PMID: 20673989